Log in

NYSE:ASPNAspen Aerogels Stock Price, Forecast & News

$6.25
-0.34 (-5.16 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.24
Now: $6.25
$6.61
50-Day Range
$5.86
MA: $6.64
$7.95
52-Week Range
$4.09
Now: $6.25
$10.71
Volume105,400 shs
Average Volume224,319 shs
Market Capitalization$166.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.63
Aspen Aerogels, Inc., an aerogel technology company, designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets worldwide. The company provides Pyrogel XT-E that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market with operating temperatures greater than 400 C; Pyrogel XTF to provide strong protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. In addition, the company provides contract research services for the Department of Defense, the Department of Energy, and other institutions. Aspen Aerogels, Inc. was founded in 2001 and is headquartered in Northborough, Massachusetts.
Read More
Aspen Aerogels logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.51 out of 5 stars


Industry, Sector and Symbol

Industry Lumber & other construction materials
Sub-IndustryN/A
CUSIPN/A
Phone508-691-1111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$139.38 million
Book Value$2.43 per share

Profitability

Net Income$-14,560,000.00

Miscellaneous

Employees295
Market Cap$166.19 million
Next Earnings Date7/30/2020 (Confirmed)
OptionableNot Optionable

Receive ASPN News and Ratings via Email

Sign-up to receive the latest news and ratings for ASPN and its competitors with MarketBeat's FREE daily newsletter.

Aspen Aerogels (NYSE:ASPN) Frequently Asked Questions

How has Aspen Aerogels' stock been impacted by COVID-19 (Coronavirus)?

Aspen Aerogels' stock was trading at $6.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ASPN shares have decreased by 3.8% and is now trading at $6.25. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Aspen Aerogels?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspen Aerogels in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aspen Aerogels.

When is Aspen Aerogels' next earnings date?

Aspen Aerogels is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Aspen Aerogels.

How can I listen to Aspen Aerogels' earnings call?

Aspen Aerogels will be holding an earnings conference call on Thursday, July 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Aspen Aerogels' earnings last quarter?

Aspen Aerogels Inc (NYSE:ASPN) issued its quarterly earnings results on Thursday, April, 30th. The construction company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.22) by $0.09. The construction company had revenue of $28.42 million for the quarter, compared to analysts' expectations of $28.58 million. Aspen Aerogels had a negative net margin of 8.39% and a negative return on equity of 18.86%. View Aspen Aerogels' earnings history.

What price target have analysts set for ASPN?

6 Wall Street analysts have issued 1-year price objectives for Aspen Aerogels' shares. Their forecasts range from $9.00 to $15.00. On average, they anticipate Aspen Aerogels' stock price to reach $11.20 in the next twelve months. This suggests a possible upside of 79.2% from the stock's current price. View analysts' price targets for Aspen Aerogels.

Has Aspen Aerogels been receiving favorable news coverage?

Headlines about ASPN stock have trended negative this week, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aspen Aerogels earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave news stories about the construction company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Aspen Aerogels.

Who are some of Aspen Aerogels' key competitors?

What other stocks do shareholders of Aspen Aerogels own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspen Aerogels investors own include Intelsat (I), Bank of America (BAC), Fossil Group (FOSL), AMC Entertainment (AMC), Gilead Sciences (GILD), Apollo Global Management (APO), Associated British Foods (ABF), Chaarat Gold (CGH), China Unicom (Hong Kong) (CHU) and Ciena (CIEN).

Who are Aspen Aerogels' key executives?

Aspen Aerogels' management team includes the following people:
  • Mr. Donald R. Young, Pres, CEO & Director (Age 62)
  • Mr. John F. Fairbanks, VP, CFO & Treasurer (Age 58)
  • Mr. Corby C. Whitaker, Sr. VP of Sales & Marketing (Age 49)
  • Mr. Jeffrey Alan Ball, VP of Operations (Age 51)
  • Dr. George L. Gould, Chief Technology Officer (Age 56)

What is Aspen Aerogels' stock symbol?

Aspen Aerogels trades on the New York Stock Exchange (NYSE) under the ticker symbol "ASPN."

How do I buy shares of Aspen Aerogels?

Shares of ASPN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aspen Aerogels' stock price today?

One share of ASPN stock can currently be purchased for approximately $6.25.

How big of a company is Aspen Aerogels?

Aspen Aerogels has a market capitalization of $166.19 million and generates $139.38 million in revenue each year. The construction company earns $-14,560,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. Aspen Aerogels employs 295 workers across the globe.

What is Aspen Aerogels' official website?

The official website for Aspen Aerogels is www.aerogel.com.

How can I contact Aspen Aerogels?

Aspen Aerogels' mailing address is 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532. The construction company can be reached via phone at 508-691-1111 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.